Quest Diagnostics provides objective information to assist healthcare providers in identifying the presence or
absence of drugs or drug classes in the body, and making informed treatment decisions.
Our expert toxicologists, MDs, and PhDs share unique insights, research, and latest trends in drug monitoring and impact on the drug epidemic across the nation.
According to an Ideas and Opinions article published in the Annals of Internal Medicine (2 April 2020), the government needs to do more to help patients with opioid use disorder (OUD) to weather the COVID-19 pandemic. William Becker, MD, and David Fiellen, MD, both of the Yale Program in Addiction…